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Abstract
Background: Chest wall injury after stereotactic radiotherapy (SRT) for primary lung cancer has recently been
reported. However, its detailed imaging findings are not clarified. So this study aimed to fully characterize the
findings on computed tomography (CT), appearance time and frequency of chest wall injury after stereotactic
radiotherapy (SRT) for primary lung cancer
Materials and methods: A total of 177 patients who had undergone SRT were prospectively evaluated for
periodical follow-up thin-section CT with special attention to chest wall injury. The time at which CT findings of
chest wall injury appeared was assessed. Related clinical symptoms were also evaluated.
Results: Rib fracture was identified on follow-up CT in 41 patients (23.2%). Rib fractures appeared at a mean of
21.2 months after the completion of SRT (range, 4 -58 months). Chest wall edema, thinning of the cortex and
osteosclerosis were findings frequently associated with, and tending to precede rib fractures. No patients with rib
fracture showed tumors > 16 mm from the adjacent chest wall. Chest wall pain was seen in 18 of 177 patients
(10.2%), of whom 14 patients developed rib fracture. No patients complained of Grade 3 or more symptoms.
Conclusion: Rib fracture is frequently seen after SRT for lung cancer on CT, and is often associated with chest wall
edema, thinning of the cortex and osteosclerosis. However, related chest wall pain is less frequent and is generally
mild if present.
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Background
Stereotactic radiotherapy (SRT) for primary lung cancer
has recently attracted attention because of its promising
treatment effects [1-10]. A recent report demonstrated
that SRT achieved a good survival rate for patients with
non-small cell lung carcinoma, comparable to those of
surgery [10]. SRT has now been applied not only to
medically inoperable patients but also to operable ones.
In the near future, SRT might become an alternative
treatment to surgery for stage I non-small lung
carcinoma.
One major concern that must always been taken into
consideration when selecting treatment methods is
treatment sequelae. SRT is generally considered a safe
treatment, with fewer complications than surgery.
However, several studies have reported complications
in SRT, such as radiation pneumonitis [11,12] and
chest wall injury, including rib fracture [5-7,13-16].
Frequencies of rib fracture after SRT have already been
reported in several investigations. However, detailed
CT findings of chest wall injury have yet to be
clarified.
The present study therefore aimed to fully character-
ize detailed CT findings of chest wall injury after SRT
for primary lung cancer using thin-section CT. * Correspondence: nambu-a@gray.plala.or.jp
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The institutional review board approved all study proto-
cols. Written informed consent was obtained from all
patients prior to participation in this study.
Patients
Between November 2001 and April 2009, a total of 210
patients with primary non-small cell lung carcinoma
underwent SRT in our institution. Of these patients, 177
patients agreed to participate in this prospective study.
Patient characteristics are summarized in Table 1.
Methods of radiotherapy
SRT was performed using noncoplanar 10 dynamic arcs.
A total dose of 48-70Gy at the isocenter was adminis-
tered in 4-10 fractions, and approximately 80% isodose
line of prescribed dose covered planning target volume
(PTV) using a 6 MV X-ray, comprising three different
methods, namely 48Gy/4fractions, 60Gy/10fractions, and
70Gy/10fractions, (Table 1). We essentially used 60Gy/
10fractions but when tumor measured more than 3 cm
(i.e. T2) 70Gy/10fractions was used, and cases that were
registered in a certain clinical trial were treated with
48Gy/4fractions. The dose was not constrained by sur-
rounding normal tissues including chest wall. Heteroge-
neity corrections were made in all cases.
After adjusting the isocenter of the PTV to the
planned position in a unit comprising a CT scanner and
linear accelerator, irradiation was performed under
patient-controlled breath-holding and radiation beam
switching.
CT examination
Preradiotherapeutic and follow-up CT were performed
using the same 16 multidetector row scanner (Aquilion
16 (Toshiba Medical Systems, Otawara, Japan)) and with
the identical protocols.
Parameters for CT scanning were as follows: peak vol-
tage 120 kVp, tube rotation time 0.5 second, slice colli-
mation 1.0 mm, and beam pitch 0.94. Tube currents
were determined by an automatic exposure control with
the noise factor for determining the applied tube current
was set at 11 (standard deviation) and the tube currents
actually ranging from 110 to 400 mA.
Contrast-enhanced CT was performed for 116 patients
(67.1%) after unenhanced CT. Contrast material (Omni-
paque 300, Daiichi Sankyo, Tokyo) in a volume tailored
to the body weight of each patient (600 mg iodine/kg
body weight) was injected from the anterior cubital vein
within a fixed injection time of 50 s (i.e. injection rate
was variable.). CT scans were started at 60 and 120 s
after beginning of the contrast injection.
These data were reconstructed into 5 mm sections.
Thin-section CT (slice thickness, 1 mm) was also pro-
duced for regions that included tumor or radiation-
induced opacities targeting the affected lung, which was
mainly used for the evaluation of chest wall injury.
Preradiotherapeutic CT was performed within 1
month before SRT, while follow-up CT was performed
at 3 and 6 months after the completion of the radiother-
apy, and every 6 months thereafter.
CT evaluation
Preradiotherapeutic CT was interpreted by either of two
chest radiologists (A.N, E.S) in our institution. Maxi-
mum tumor size and the shortest distance between the
tumor margin and chest wall (tumor-chest wall dis-
tance) were measured on 1 mm contrast-enhanced CT
with a reconstruction kernel for viewing lung parench-
yma as a part of the radiology report. Maximum tumor
size was defined as the maximum dimension of a tumor
in all of axial CT sections that included the tumor.
Follow-up CT was also examined by either of the
same radiologists with special attention to abnormal
findings of the chest wall in addition to routine radiolo-
gical assessment. Rib fracture in this study was defined
as a disruption of cortical continuity with malalignment.
Thinning of cortex was defined as a focal area of cortex
with a thickness less than half of the surrounding nor-
mal cortex. Osteosclerosis was defined as an area of
increased attenuation comparable to cortex in the
medulla of rib.
The time at which each finding first appeared after the
completion of SRT was reviewed. Final outcomes of rib
Table 1 Characteristics of the 177 primary lung cancer patients enrolled in this study
Lung cancer patients (n = 177)
*Average age(range) 77.3 ± 7.0 (55-92)
*Gender (male: female) 132:45
**Range of follow-up period (median) 11-99 (27)
Tumor diameter (average ± standard deviation) 8-55 mm(30.0 ± 9.1)
central tumors: peripheral tumors 22:155
Method of radiotherapy (48Gy/4fr:60Gr/10fr:70Gr/10fr) 75:37:65
*Presented as mean ± standard deviation.
**Presented as median.
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on follow-up CT.
Follow-up of patients
Every patient was basically asked to visit our clinic at
3, 6, and every 6 months thereafter after the comple-
tion of radiotherapy. At every visit, a thorough exami-
nation was performed, consisting of inquiry focusing
on pain at the chest wall near the irradiated tumor
and respiratory symptoms, physical examination by an
attending radiation oncologist, blood test, and CT.
Clinical symptoms considered related to chest wall
injury after SRT were graded according to the criteria
for pain in Common Terminology Criteria for Adverse
Events, version. 3. Chest radiologists interpreted the
results of CT just after the examinations. If the patient
complained of pain, analgesics were prescribed as
appropriate.
Evaluation of dosimetry
Among the 177 patients, detailed dosimetries were avail-
able for review in 26 patients with rib fracture and 22
patients without. Patients without fracture were ran-
domly sampled among those with no evidence of frac-
ture on CT for more than 30 months. We set this
period as a cut-off point as most rib fractures after SRT
in this series had occurred within 30 months after com-
p l e t i o no fS R T .A tt h ep o i n to nt h ec h e s tw a l lt h a th a d
received the maximum dose, BED was calculated in
each case assuming the a/b ratio as 3 (BED3) (Figure 1).
The chest wall volume (cc) that received in BED3 ≥ 50
Gy was also calculated.
Data analysis
Data analyses were performed retrospectively using the
prospectively interpreted radiology reports.
First, we calculated the crude incidence of rib fracture
after SRT on follow-up CT during the follow-up periods
of the patients. As crude incidence may underestimate
actual incidence of rib fracture, we also performed a
Kaplan-Meier method to obtain a more accurate esti-
mate of incidence of rib fracture. We also assessed the
relationship between rib fracture and related findings in
terms of time frame.
A
B
Figure 1 An 86-year old woman with adenocarcinoma. A:Dosimetry overlaying CT shows the maximum prescribed dose of chest wall as
63Gy, with a BED3 of 233.2Gy. B: Rib fracture was noted at 24 months after completion of SRT. Amorphous osteosclerosis is also seen (arrow).
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distance on preradiotherapeutic CT to discriminate
patients who with rib fractures from those without. Fre-
quencies of rib fracture when the tumor-chest wall dis-
tance was less than or equal to the threshold distance
and when the distance was 0 mm were also calculated.
Third, we evaluated the frequency of clinical
symptoms.
Fourth, mean BED3 and BED3 ≥ 50 Gy were calcu-
lated in fracture and non-fracture groups and were com-
pared between the two groups using unpaired t test.
Fisher’se x a c tt e s to rc
2 test was used to see differences
between groups.
Value of p < 0.05 were considered statistically
significant.
All statistical analyses were performed using IBM
SPSS Statistics version 18(New York, USA).
Results
Frequency of rib fractures after SRT
The crude incidence of rib fracture was 23.2% (41/177)
at a median follow-up of 27 months (Table 2). The fre-
quency of rib fracture was not statistically different
among the three different dose fractionations (c2 test, p
= 0.391). Kaplan-Meier method estimated the incidence
to be 27.4% at 24 months.
Imaging findings of rib fracture and related findings and
appearance times
Results of appearance time and frequency of rib frac-
tures are summarized in Table 2. Rib fractures appeared
at a mean of 21.2 months (range, 4 -58 months) on fol-
low-up CT. Fractures invariably occurred at the ribs
close to the irradiated tumor, and were solitary or multi-
ple (Figure 2). Final outcomes for fractures were non-
union in 28 patients, including 14 patients with pseu-
doarthrosis (defined as covering of cortex over the frac-
tured surface), and bony union in 13. Chest wall edema
was seen in 45 of 177 patients (25.4%), appearing at a
mean of 12 months after SRT (range, 2 -57 months).
Such edema was seen as asymmetrical swelling of the
ipsilateral chest wall compared with the contralateral
chest wall along with effacement of interlaced
intramuscular fat attenuation. Low-attenuation areas in
the chest wall were occasionally associated, which
became more conspicuous on contrast- enhanced CT
(Figure 3). Thinning of the cortex was observed in 36
patients (30.3%) at 4 to 36 months. Osteosclerosis was
evident in 26 patients (14.7%) on follow-up CT at a
mean of 15 months (range, 4-57 months). This finding
appeared as mottled sclerosis of the affected bone (Fig-
ure 4). These findings related to rib fracture typically
preceded the identification of rib fracture.
Symptoms of rib fracture
Clinical symptoms in patients with rib fracture and
without rib fracture are summarized in Table 3. Chest
wall pain was seen in 18 of 177 patients (10.2%), of
whom 14 patients developed rib fracture. No patients
complained of Grade 3 or more symptoms. Four
patients without rib fractures complained of Grade 1
chest wall pain with all 4 cases showing radiological evi-
dence of chest wall edema. In the study population as a
whole, the frequency of chest wall pain was 21.5% (38/
177). The frequency of chest wall pain was not signifi-
cantly different between the patients with union (6/13,
46%) and non-union (7/28, 25%) rib fracture (Fisher’s
exact test, p = 0.160).
Threshold tumor-chest wall distance in the occurrence of
rib fracture
Mean tumor-chest wall distance was 12.3 mm (range, 0
- 53 mm). No patients with rib fracture showed a
tumor-chest wall distance > 16 mm, while frequency of
rib fracture was 31.3% (41/131) for a distance ≤ 16 mm,
and 37.1% at 24 months by Kaplan-Meier method.
When the distance was 0 mm, frequency of rib fracture
was 36.7% (22/60) and 51.8% at 24 months by Kaplan-
Meier method (Table 4).
Maximum BED3 of the chest wall in patients with and
without rib fracture, and threshold dose for rib fracture
occurrence Mean BED3 of the chest wall was 240.7 ±
38.7 in 26 patients with rib fracture and 146.8 ± 74.5 in
22 patients without rib fracture, representing a signifi-
cant difference between groups (p < 0.001). The lowest
BED3 that resulted in rib fracture was 152.4 Gy. Mean
Table 2 Appearance time and frequencies of the rib fractures and related findings
Appearance time ranges
(months)*
Crude frequency of each
finding
Frequency at 24 months by Kaplan-Meier
method
Rib fracture 21.2 (4-58) 41/177(23.2%) 27.4%
Thinning of the
cortex
15.6 (4-36) 36/177 (20.3%)
Osteosclerosis 14.7 (4-57) 26/177(14.7%)
Chest wall edema 12.0 (2-57) 45/177 (25.4%)
*Presented as mean (range).
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45.0cc in the fracture group and 50.1 ± 59.8 in the non-
fracture group, again representing a significant differ-
ence (p < 0.001). The minimum volume that resulted in
rib fracture was 25cc.
Discussion
Our results demonstrated that the development of rib
fracture after SRT is not uncommon with a frequency of
23.2% for the whole study population. Not unexpectedly,
frequency increased with closer proximity of the tumors
to the chest wall, from 31.3% ≤16 mm to 36.7% at 0 mm.
The reported frequencies of rib fracture after SRT vary
widely among investigators, ranging from 3% to 21.2%
[5-7,13-16]. Our result is closest to that reported by Pet-
terson, et al., who reported the highest frequency (21.2%)
among the previous reports [14]. We speculate that these
discrepancies are mainly caused by differences in the
methods for estimating frequency. Petterson, et al. and the
present study obtained frequencies based on follow-up
CT, whereas other studies based frequencies on findings
for patients who complained symptoms. That is, differ-
ences may be largely due to whether asymptomatic
patients with rib fracture were likely to be included in fre-
quency calculations. Our clinical experience supports this
speculation. Differences in follow-up periods, methods of
SRT or the proportion of tumors close to the chest wall
may also have contributed to the discrepancies between
studies. The frequency of rib fracture reported by Petter-
son, et al. is still lower than our result despite the fact that
they used a higher prescribed SRT dose than we did. This
may be because thin-section CT in the present study may
have allowed sensitive detection of rib fracture.
In Kaplan-Meier method, the frequency of rib fracture
was calculated to be even higher (27.4% at 24 months).
This incidence is considered to be a more accurate esti-
mate of frequency of rib fracture as there were censored
cases during the follow-up periods.
The frequency of rib fracture is also more common in
SRT for lung cancer than in breast conserving surgery
combined with radiotherapy, which has a reported fre-
quency of 0.3-2.2% [17,18], probably due to much higher
A
B
C D
Figure 2 An 85-year-old man with a rib fracture after SRT. A, A preradiotherapeutic thin-section CT showing a spiculated nodule with air-
containing spaces (arrow). B, Seven months later after SRT, CT shows edema of the right chest wall adjacent to the tumor, as evidenced by
asymmetrical swelling and effacement of the fat planes (arrow). C, On follow-up CT at 13 months after SRT, thin-section CT with a bone window
setting demonstrates thinning of cortex with mild sclerotic foci of the medulla in a rib. D, At 20 months after SRT, rib fracture with malalignment
of the cortex is apparent (arrow).
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to the chest wall.
Rib fractures occurred at a mean of 21.2 months
(range, 4-58 months) after SRT, mostly within 30
months after completion of SRT, and were frequently
preceded by chest wall edema, thinning of the cortex of
the rib or sclerosis of the medulla of the rib. We may
summarize the typical course of chest wall injury after
A
B
C
Figure 3 A 65-year-old man with a rib fracture after SRT.A ,P r e r a d i o t h e r a p e u t i ct h i n - s e c t i on CT showing a spiculated nodule with
surrounding ground-glass opacity close to the chest wall (arrow). B, Twelve months later after SRT, a rib fracture is apparent (arrow). C, At 6
months after SRT, enhanced CT shows swelling of the left chest wall with an area of low attenuation (arrows).
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eral months after SRT chest wall edema first appears.
The cortex then becomes thinner and the medulla
sometimes becomes sclerotic in a mottled fashion, and
the affected rib eventually undergoes fracture. These CT
findings presumably correspond to soft tissue edema
and changes in bone vascularity due to increased perme-
ability or occlusion of the capillaries caused by irradia-
tion of the soft tissue, and a decrease in number of
osteoblasts resulting in decreased collagen production,
in turn causing osteopenia and subsequent bone injury
[19]. Osteosclerosis after radiotherapy is considered to
represent reactive bone formation caused by remaining
osteoblast cells [20].
Under such conditions, the rib becomes extremely
vulnerable and often fractures. Although these bone
changes may actually represent insufficiency fracture
[19], radiation osteitis [21], callous formation secondary
to microtrabecular fracture or osteonecrosis [22], we did
not use these terms as we had no pathological
confirmation of such findings. We therefore employed
the common terms for imaging findings.
We think that these preceding findings may be usable
as predictors of rib fracture. Prediction of rib fracture
may be informative to the referring physicians as well as
to patients as we might initiate treatment for chest wall
pain related to the forthcoming rib fracture in advance
or possibly take some preventive measures against rib
fractures. Although the frequency of clinical symptoms
was not high in patient with rib fracture and the clinical
symptoms were generally not severe, most symptomatic
patients had rib fracture. Therefore, prediction of rib
fracture will clinically be important.
In addition, bone sclerosis or focal loss of cortex may
be mistaken for metastasis. Familiarity with these find-
ings will therefore minimize the potential for confusion.
The outcomes of rib fracture were non-union in 28
patients, including 14 patients with pseudoarthrosis and
bony union in 13. Needless to say, the proportion of
union and non-union largely depends on the duration of
follow-up and the prescribed dose to tumors. However,
we can at least say that a substantial proportion of rib
fractures after SRT for lung cancer can remain a state of
non-union for a long time after SRT and that pseudoar-
throsis is not uncommon. However, the outcomes of rib
fracture seem unrelated to the frequency of clinical
symptoms.
A tumor-chest wall distance of 16 mm appears to
represent a threshold value, beyond which rib fracture
did not occur, in our series. This threshold offers a con-
cise and convenient reference value. Undoubtedly, the
A
BC
Figure 4 A 85-year-old woman with adenocarcinoma. A, Preradiotherapeutic thin-section CT at the bone window shows no marked
abnormality of the ribs. B, At 18 months after SRT, bone sclerosis of the rib adjacent to the lung tumor appeared (arrow). C, At 30 months after
completion of SRT, multiple rib fractures with areas of sclerosis are seen. Pseudoarthrosis is present in one of the fractured bones (arrow head).
Table 3 Frequency and degree of chest wall pain
Degree of pain* Fracture group
(n = 41)
Non-fracture group
(n = 136)
Grade 0 27 (65.9) 132(97)
Grade 1 7 (17.1) 4(3)
Grade 2 7 (17.1) 0(0)
Grade 3 and 4 0 (0) 0(0)
*The degree of chest wall pain was evaluated according to Common
Terminology Criteria for Adverse Events, Ver. 3.
**The numbers in the parentheses are percentages
Nambu et al. Radiation Oncology 2011, 6:137
http://www.ro-journal.com/content/6/1/137
Page 7 of 9risk of rib fractures depends much more on the dose
delivered to the rib and therefore a dosimetry-based eva-
luation can provide a more accurate estimate of the risk
o fr i bf r a c t u r e s .H o w e v e r ,d o s i m e t r yc a no n l yb ep r o -
duced after SRT is chosen as the treatment. Our
approach can provide a patient or referring physician
with information about the risk of rib fracture based
only on preradiotherapeutic CT before decision is made
to undergo SRT. Our result may not be simply applic-
able to patients in other institutions as prescribed doses
differ among institutions, but will be valid when pre-
scribed doses are less than or equal to our own.
Mean BED3 of the chest wall (240.7 ± 38.7 Gy) and
mean chest wall volume (cc) with BED3 ≥ 50Gy (110.3 ±
45.0cc) in 26 patients with rib fracture were much higher
than those (146.8 ± 74.5Gy and 50.1 ± 59.8cc) in 22
patients without rib fracture, with statistical significances,
respectively. These values may also be usable to predict
the risk of rib fracture. The lowest BED3 that resulted in
rib fracture was 152.4Gy. The threshold BED3 for produ-
cing rib fracture seemed to be around 150Gy, but further
investigation is necessary to make a definitive conclusion.
This study has some limitations that must be consid-
ered. First, we regarded the appearance time of rib frac-
ture and other related findings as that when these
findings were first seen on follow-up CT. However,
these events would actually have occurred within the
interval of time since the previous CT. The present
study would thus have overestimated time that elapsed
until these events.
Second, for BED3 of chest wall, only a small number of
cases from the study population were sampled. This was
because of the limited capability of our treatment planning
computer for data handling, which requires a substantial
amount of time to reproduce a dosimetry. Calculating
dosimetries of all cases is obviously the best way to obtain
a threshold BED, but we believe that our random sampling
method provided a clear and concise reference value,
which would offer a benchmark when considering risk of
rib fracture in clinical practice. Third, the method of SRT
for lung cancer has yet to be standardized. So, our results
cannot be simply applied to other institutions.
Conclusion
Rib fracture is seen with high frequency after SRT for
lung cancer when the tumor is close to the chest wall.
Chest wall edema and thinning and osteosclerosis of the
cortex represent related findings that often precede rib
fracture and might be predictive of a forthcoming rib
fracture. However, related chest wall pain is less fre-
quent and is generally mild if present.
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